Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PE

WKN: A412X3 | ISIN: CNE100006T44 | Ticker:
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
PEGBIO CO LTD Chart 1 Jahr
5-Tage-Chart
PEGBIO CO LTD 5-Tage-Chart

Aktuelle News zur PEGBIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.11.PEGBIO CO-B (02565): FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 26, 2026-
PEGBIO Aktie jetzt für 0€ handeln
11.11.PEGBIO CO-B (02565): NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING-
11.11.PEGBIO CO-B (02565): (1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING ...-
10.11.PEGBIO CO-B (02565): NEXT DAY DISCLOSURE RETURN-
10.11.PEGBIO CO-B (02565): COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE1
06.11.PEGBIO CO-B (02565): CANCELLATION OF EXTRAORDINARY GENERAL MEETING AND CANCELLATION OF BOOK CLOSURE PERIOD3
03.11.PEGBIO CO-B Places Shares at 19% Discount, Net Proceeds Exceed HKD77 million2
02.11.PEGBIO CO-B (02565): PLACING OF NEW H SHARES UNDER GENERAL MANDATE3
23.10.PEGBIO CO-B (02565): FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 12, 20261
23.10.PEGBIO CO-B (02565): NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING-
23.10.PEGBIO CO-B (02565): (1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING ...-
23.09.PEGBIO CO-B (02565): 2026 INTERIM REPORT-
18.09.PEGBIO CO-B (02565): CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING1
18.09.PEGBIO CO-B (02565): PROPOSED CHANGE OF AUDITOR-
02.09.PEGBIO CO-B (02565): VOLUNTARY ANNOUNCEMENT JOINT R&D COLLABORATION WITH SN BIOSCIENCE ADVANCING THE LONG-ACTING DEVELOPMENT OF THREE NEXT-GENERATION ...-
25.08.PEGBIO CO-B (02565): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-
13.08.Lexaria geht Partnerschaft mit PegBio zur Verabreichung von GLP-1-Wirkstoffen ein6
13.08.Lexaria enters partnership with PegBio for GLP-1 drug delivery3
13.08.Lexaria Bioscience Corp.: Lexaria Enters a Material Transfer Agreement With PegBio469KELOWNA, BC / ACCESS Newswire / August 13, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered into...
► Artikel lesen
13.08.PEGBIO CO-B (02565): DATE OF BOARD MEETING-
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1